Cerebain Biotech Releases Initial Photos of Its First Prototype of the Company's Medical Device Prod

Before you go, we thought you'd like these...
Before you go close icon

Cerebain Biotech Releases Initial Photos of Its First Prototype of the Company's Medical Device Product for Treatment of Alzheimer's

DALLAS--(BUSINESS WIRE)-- Cerebain Biotech Corp. ("Cerebain" or "the Company"), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. ("Sonos"), has provided photos of the first prototype of the Company's medical device solution for the treatment of Alzheimer's disease utilizing the Omentum.

Photo of medical device prototype (Photo: Business Wire)

Photo of medical device prototype (Photo: Business Wire)

The medical device has been developed to provide continuous Omentum stimulation, enabling substantial advancements in the treatment efficiency and the quality of life of Alzheimer's patients.


About Discount Dental Materials, Inc.

Discount Dental Materials, Inc. was incorporated in Nevada on December 17, 2007. The Company's business will revolve around the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Company's approach will consider both a medical device solution as well as a synthetic drug solution. The Company's operations will be conducted through its wholly-owned subsidiary, Cerebain Biotech Corp. For more information about Discount Dental and Cerebain Biotech, please visit the Company's website at www.cerebain.com and www.otcmarkets.com, under the ticker symbol "DDOO", to view the Company's public filings and stock quote.

Forward Looking Statements

This news release contains certain "forward- looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's reports filed with OTC Markets. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved.

anImage


Discount Dental Materials, Inc.
Mr. Eric Clemons, President, 949-415-7478
info@cerebain.com

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:

The article Cerebain Biotech Releases Initial Photos of Its First Prototype of the Company's Medical Device Product for Treatment of Alzheimer's originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners